In March 2014, K2M filed with the U.S. Securities and Exchange Commission for an initial public offering. Today the company announced the price of it's initial public offering: $15 per share.
Spinal Tech
Nextremity Solutions announced the full launch of the Re+Line Bunion Correction System in the United States for bunion correction surgery.
Aperion Biologics announced the appointment of France Dixon Helfer and Mike Ward to its board of directors.
Medtronic announced that it has agreed to settle its inventories of filed and unfiled product liability claims related to Infuse Bone Graft.
Mazor Robotics is a developer of robotic guidance systems and complementary products. Its flagship product is the Renaissance surgical guidance system, which has been used in the placement of over 45,000 implants worldwide.
Conventus Orthopaedics has closed on a $10 million credit facility to help fund the commercialization of its Conventus DRS technology as well as new indications for the technology.
Dr. Dimitry Dzukaev has performed the first series of successful spine procedures utilizing Mazor Robotics Renaissance Guidance System with full integration of an intraoperative imaging system in Moscow, Russia.
Ortho Kinematics announced its Vertebral Motion Analysis technology, a new diagnostic technology, allows for advanced, reliable and precise spine diagnostic testing, according to a study published in The Spine Journal.
NuVasive has reached a favorable settlement agreement with Cadwell Laboratories in a lawsuit involving NuVasive's patented neuromonitoring technology.
Global spine device company LDR was highlighted in six presentations at the International Society for the Advancement of Spine Surgery annual meeting last week.
